Heritas Capital co-leads Hummingbird Bioscience's extended Series A

Heritas Capital co-leads Hummingbird Bioscience's extended Series A

Antibody visual sourced from Hummingbird's website

Deviana Chuo

10 July, 2019

Decheng CapitalHeritas Capital ManagementHummingbird BioscienceSEEDS Capital

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter

Read more from Singapore

Nikkei Logo
DealStreetAsia Logo
About Us
Team
Advertise
Contact
Careers
Blog
Privacy Policy
Terms & Conditions
© Copyright DEALSTREETASIA 2014-2025 All rights reserved.